Dopamine penetrates to the central nervous system in developing rats

Pediatrics International

Volumn 41, Issue 4, 1999, Pages 363-368

  Miyaguchi, Hideki ^a,b   Kato, Ineko ^a   Sano, Tadashi ^a   Sobajima, Hisanori ^a   Fujimoto, Shinji ^a   Togari, Hajime ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NONE   (Japan)

Author keywords

Blood brain barrier; Developing rat; Dopamine

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; INFANCY; INTRAPERITONEAL DRUG ADMINISTRATION; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DOPAMINE; RATS; RATS, WISTAR;

EID: 0032793238     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01084.x     Document Type: Article

References (21)

1. 1 Bertler A, Falck B, Owman C, Rosengrenn E. The localization of monoaminergic blood-brain barrier mechanisms. Pharmacol. Rev. 1966; 18: 369-85.
2. 2 Kopin IJ. Measuring turnover of neurotransmitters in human brain. In: Lipton MA, DiMascio A, Killam KF (eds). Psychopharmacology: A generation of progress. Raven Press, New York, 1978; 933-42.
3. 3 Hardebo IE, Owman CH. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface. Ann. Neurol. 1980; 8: 1-11.
4. 4 Saunders NR. Ontogeny of the blood brain barrier. Exp. Eye Res. 1977; 25 (Suppl.): 523-50.
5. 5 Rapoport SI. Blood-brain Barrier in Physiology and Medicine. Raven Press, New York, 1976; 79-81.
6. 6 Seri I, Tulassay T, Kiszel J et al. Effect of low-dose dopamine therapy on catecholamine values in cerebrospinal fluid in preterm neonates. J. Pediatr. 1984; 105: 489-91.
7. 7 Loizou LA. Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat. Br. J. Pharmacol. 1970; 40: 800-13.
8. 8 Watanabe T, Matsuhashi K, Takayama S. Placental and blood-brain barrier transfer following prenatal and postnatal exposures to neuroactive drugs: Relationship with partition coefficient and behavioral teratogenesis. Toxicol. Appl. Pharmacol. 1990; 105: 66-77.
9. 9 Johnston MV, Singer HS. Brain neurotransmitters and neuromodulators in pediatrics. Pediatrics 1982; 70: 57-68.
10. 10 Guldberg HC, Yates CM. Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid. Br. J. Pharmacol. Chemother. 1968; 33: 457-71.
11. 11 Dobbing J. The later development of the brain and its vulnerability. In Davis JA, Dobbing J (eds). Scientific Foundations of Pediatrics, 2nd edn. University Park Press, Baltimore, 1981; 744-59.
12. 12 Mayer G, Shoup RE. Simultaneous multiple electrode liquid chromatographic-electrochemical assay for catecholamines, indoleamines and metabolites in brain tissue. J. Chromatogr. A 1983; 255: 533-44.
13. 13 Martin RJ, Bailey BA, Downer RGH. Rapid estimation of catecholamines, octopamine and 5-hydroxytryptamine in biological tissues using high-performance liquid chromatography with coulometric detection. J. Chromatogr. A 1983; 278: 265-74.
14. 14 Matson WR, Langlais P, Volicer L, Gamache PH, Bird E, Mark KA. n-Electrode three-dimensional liquid chromatography with electrochemical detection for determination of neurotransmitters. Clin. Chem. 1984; 30: 1477-88.
15. 15 Achilli G, Perego C, Ponzio F. Application of the dual-cell coulometric detection: A method for assaying monoamines and their metabolites. Anal. Biochem. 1985; 148: 1-9.
16. 16 Kilpatrick IC, Jones MW, Phillipson OT. A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: An isocratic HPLC technique employing coulometric detection and minimal sample preparation. J. Neurochem. 1986; 46: 1865-76.
17. 17 Kurata K, Kurachi M, Hasegawa M, Kido H, Yamaguchi N. A simultaneous analytical method for catecholamines, indoleamines, and related compounds in 11 rat brain regions. Jpn. J. Psychiatry Neurol. 1987; 41: 291-300.
18. 18 Carlsson A, Hillarp N-A. Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta Physiol. Scand. 1962; 55: 95-100.
19. 19 Stewart PA, Hayakawa EM. Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier. Brain Res. Dev. Brain Res. 1987; 32: 271-81.
20. 20 Laterra JJ, Stewart PA, Goldstein GW. Development of the blood-brain barrier. In Polin RA, Fox WW (eds). Fetal and neonatal physiology. WB Saunders, Philadelphia, 1992; 1525-31.
21. 143,4-dihydroxyphenylalanine. Experientia 1962; 18: 512-3.